National Institute of General Medical Sciences; Notice of Closed Meeting, 21969-21970 [E8-8720]

Download as PDF Federal Register / Vol. 73, No. 79 / Wednesday, April 23, 2008 / Notices DATS 2: Coordinating Center and Data and Safety Monitoring Board Support. Date: May 20, 2008. Time: 9:30 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401, (301) 435–1439, lf33c.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: April 16, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–8716 Filed 4–22–08; 8:45 am] National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on PROD1PC66 with NOTICES Dated: April 16, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–8719 Filed 4–22–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Mathematical Cognition and Specific Learning Disabilities. Date: April 29, 2008. Time: 2 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Child Health and Human Development, 6100 Executive Blvd., 5B01, Bethesda, MD 20892. Contact Person: Anne Krey, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, 301–435– 6908. This notice is being published less than 15 days prior to the meeting due to the timing Jkt 214001 BILLING CODE 4140–01–M National Institute on Drug Abuse; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES 16:58 Apr 22, 2008 Dated: April 16, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–8717 Filed 4–22–08; 8:45 am] Contact Person: Jose F Ruiz, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6101 Executive Blvd., Rm. 213, MSC 8401, Bethesda, MD 20892, 301–451–3086, ruizjf@nida.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) National Institutes of Health BILLING CODE 4140–01–M VerDate Aug<31>2005 limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) 21969 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; The Interaction of HIV, Drug Abuse and Criminal Justice System. Date: May 22, 2008. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kristen V Huntley, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401, 301–435–1433, huntleyk@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Initial Review Group; Medication Development Research Subcommittee. Date: June 2, 2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; NIH Support for Conferences and Scientific Meetings. Date: April 29, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, Room 3AN18, 45 Center Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Margaret Weidman, PhD, Scientific Review Administrator, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3ANI8B, Bethesda, MD 20892, 301–594–3663, weidmanma@nigms.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry E:\FR\FM\23APN1.SGM 23APN1 21970 Federal Register / Vol. 73, No. 79 / Wednesday, April 23, 2008 / Notices Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: April 16, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–8720 Filed 4–22–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency 835, 500 C Street, SW., Washington, DC 20472. Hand Delivery/Courier: Office of the Chief Counsel, Federal Emergency Management Agency, Room 835, 500 C Street, SW., Washington, DC 20472. Instructions: All submissions received must include the Docket ID FEMA– 2007–0008. Comments received will also be posted without alteration at https://www.regulations.gov, including any personal information provided. Docket: For access to the docket to read background documents or comments received by the National Advisory Council, go to https:// www.regulations.gov. [Docket ID FEMA–2007–0008] FOR FURTHER INFORMATION CONTACT: National Advisory Council Alyson Price, Designated Federal Officer, Federal Emergency Management Agency, 500 C Street, SW., (E Street, 3rd Floor), Washington, DC 20472, telephone 202–646–3746, fax 202–646– 3061, and e-mail FEMA-NAC@dhs.gov. Federal Emergency Management Agency, DHS. ACTION: Notice of Federal Advisory Committee Meeting. mstockstill on PROD1PC66 with NOTICES AGENCY: SUMMARY: This notice announces the date, time, location and agenda for the next meeting of the National Advisory Council (NAC). At the meeting, the newly formed subcommittees will be reporting back regarding their work since the meeting in February, 2008. The meeting will be open to the public. DATES: Meeting Dates: Wednesday, May 14, 2008, from approximately 9 a.m. to 5 p.m. and Thursday, May 15, 2008, 9 a.m. to 3:30 p.m. A public comment period will take place on the afternoon of May 15, 2008, approximately between 2:30 p.m. and 3 p.m. Comment Date: Written comments or requests to make oral presentations must be received by May 6, 2008. ADDRESSES: The meeting will be held at the Four Points by Sheraton, 10249 W. Irving Park Road, Chicago, IL. Persons wishing to make an oral presentation or who are unable to attend or speak at the meeting may submit written comments. Written comments and requests to make oral presentations at the meeting should be provided to the address listed below and must be received by May 6, 2008. All submissions received must include the Docket ID FEMA–2007–0008 and may be submitted by any one of the following methods: Federal Rulemaking Portal: https:// www.regulations.gov. Follow instructions for submitting comments on the Web site. E-mail: FEMA-RULES@dhs.gov. Include Docket ID in the subject line of the message. Facsimile: (866) 466–5370. Mail: Office of Chief Counsel, Federal Emergency Management Agency, Room VerDate Aug<31>2005 16:58 Apr 22, 2008 Jkt 214001 Notice of this meeting is given under the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C. App. 1 et seq.). The NAC will meet for the purpose of reviewing the progress of the newly formed subcommittees, will receive an update on the Regional Advisory Councils, transition issues and other matters. Public Attendance: The meeting is open to the public. Please note that the meeting may close early, if all business is finished. Persons with disabilities who require special assistance should advise the Designated Federal Officer of their anticipated special needs as early as possible. Members of the public who wish to make comments on Thursday May 15, between 2:30 p.m. and 3 p.m. are requested to register in advance. In order to allow as many people as possible to speak, speakers are requested to limit their remarks to 3 minutes. For those wishing to submit written comments, please follow the procedure noted above. SUPPLEMENTARY INFORMATION: Dated: April 15, 2008. R. David Paulison, Administrator, Federal Emergency Management Agency. [FR Doc. E8–8828 Filed 4–22–08; 8:45 am] BILLING CODE 9111–48–P PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Country of Origin Marking for the Republic of Kosovo Customs and Border Protection, Department of Homeland Security; Department of the Treasury. ACTION: Notice of policy. AGENCIES: SUMMARY: On February 18, 2008, the United States recognized the Republic of Kosovo as a sovereign and independent state and announced that full diplomatic relations would begin immediately. This document notifies the public of the name and English spelling that is to be used for country of origin marking on merchandise imported into the United States from the Republic of Kosovo. The notice also establishes a transition period during which Customs and Border Protection (CBP) will permit the importation of merchandise from the newly independent state with the marking, ‘‘Serbia.’’ DATES: April 23, 2008. FOR FURTHER INFORMATION CONTACT: Richard Mojica, Regulations and Rulings, Office of International Trade, (202) 572–8789. SUPPLEMENTARY INFORMATION: Background Section 304 of the Tariff Act of 1930, as amended (19 U.S.C. 1304), provides that, unless excepted, every article of foreign origin (or its container) imported into the United States shall be marked in a conspicuous place as legibly, indelibly, and permanently as the nature of the article (or its container) will permit, in such a manner as to indicate to the ultimate purchaser in the United States the English name of the country of origin of the article. Customs and Border Protection (CBP) has authority pursuant to 19 U.S.C. 1304 to determine the character of the words and phrases or abbreviations thereof that will be acceptable as indicating the country of origin, and may require the addition of any other words or symbols which may be appropriate to prevent deception or mistake as to the origin of the article. In view of the political independence of the Republic of Kosovo, and in recognition of their independent status by the United States as of February 18, 2008, merchandise originating in that country and imported into the United States is subject to marking with the English name of the independent state. The short form English name of the E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 73, Number 79 (Wednesday, April 23, 2008)]
[Notices]
[Pages 21969-21970]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8720]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; NIH Support for Conferences and 
Scientific Meetings.
    Date: April 29, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, Room 
3AN18, 45 Center Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Margaret Weidman, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Institute of 
General Medical Sciences, National Institutes of Health, 45 Center 
Drive, Room 3ANI8B, Bethesda, MD 20892, 301-594-3663, 
weidmanma@nigms.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry

[[Page 21970]]

Research; 93.862, Genetics and Developmental Biology Research; 
93.88, Minority Access to Research Careers; 93.96, Special Minority 
Initiatives, National Institutes of Health, HHS)

    Dated: April 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-8720 Filed 4-22-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.